Nikkei 225 (N225) is currently on bearish momentum. At 17:11 EST on Friday, 14 May, Nikkei 225 (N225) is at 28,084.47, 5.51% down since the last session’s close.
Nikkei 225 Range
About Nikkei 225’s daily highs and lows, it’s 2.55% up from its trailing 7 days low of $27,385.00 and 5.39% down from its trailing 7 days high of $29,685.40.
Regarding Nikkei 225’s yearly highs and lows, it’s 51.37% up from its 52-week low and 8.56% down from its 52-week high.
Nikkei 225’s last week, last month’s, and last quarter’s current volatility was a negative 1.42%, a negative 0.32%, and a positive 1.04%, respectively.
Nikkei 225’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.79% (last week), 1.03% (last month), and 1.04% (last quarter), respectively.
Index Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225’s is considered to be overbought (>=80).
Last news about Nikkei 225 (N225)
Nikkei 225 tumbles 3% in tech-led selloff on inflation concerns. According to Bloomberg Quint on Tuesday, 11 May, "The Nikkei 225 Stock Average slid more than 3% in its worst drop since Feb. 26, with SoftBank Group Corp. and Tokyo Electron Ltd. "
News about S&P 500
According to Bloomberg Quint on Tuesday, 11 May, "Exxon has roundly rebuffed the activist’s proposals, recently appointing three new directors of its own, introducing new emissions targets and cutting spending to protect the S&P 500 Index’s third-largest dividend, worth $15 billion a year. ", "After posting its first loss in four decades and taking on record debt last year, Exxon’s stock is up more than 50% in 2021, outperforming the S&P 500 Energy Index by about 10 percentage points."
According to Business Insider on Tuesday, 11 May, "The Dow hit a record intraday high before finishing 0.1 percent lower, while the S&P 500 fell over 1 percent and the tech-heavy Nasdaq Composite tumbled as much as 2.6 percent after negative analyst comments."
According to MarketWatch on Tuesday, 11 May, "From mRNA vaccines reaching people’s arms to combating climate change, the opportunity to work with programmed cells has never been more apparent." Soaring Eagle’s stock, which went public on April 19, fell 1.2% on Monday to close at a fresh low of $9.94, on a day that the Renaissance IPO ETF declined 1.6% and the S&P 500 lost 1.0%."
According to MarketWatch on Tuesday, 11 May, "Shares have fallen 3.6% in the year through Monday, while the S&P 500 has gained 11.5%."
More news about Nikkei 225 (N225).